Evidence map›Paper›PMID 30392628›Full record

ArticleJournal of the American Academy of Child and Adolescent Psychiatry2018

Maternal Serotonin Levels Are Associated With Cognitive Ability and Core Symptoms in Autism Spectrum Disorder.

Alicia K Montgomery, Lauren C Shuffrey, Stephen J Guter, George M Anderson, Suma Jacob, Matthew W Mosconi, John A Sweeney, J Blake Turner, James S Sutcliffe, Edwin H Cook and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Academy of Child and Adolescent Psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Autism and Cortical Thickness Deviation From Neurotypical Controls: Evidence for a Spatial Association With Serotonin Receptors.Autism research : official journal of the International Society for Autism Research · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Contribution of the serotonergic system to developmental brain abnormalities in autism spectrum disorder.Autism research : official journal of the International Society for Autism Research · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Gestational Factors throughout Fetal Neurodevelopment: The Serotonin Link.International journal of molecular sciences · 2020
    Review
  17. Article
  18. Blood platelet research in autism spectrum disorders: In search of biomarkers.Research and practice in thrombosis and haemostasis · 2019
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 10 institutions in 1 country.

Alicia K MontgomeryColumbia University Medical Center, New York, NY, and the New York State Psychiatric Institute, New York, NY; Center for Autism and the Developing Brain, New York-Presbyterian Hospital, White Plains, NY.
Lauren C ShuffreyNew York State Psychiatric Institute, New York, NY, and the Center for Autism and the Developing Brain, New York-Presbyterian Hospital, White Plains, NY. They are also with the Sackler Institute for Developmental Psychobiology; Columbia University Medical Center, New York, NY.
Stephen J GuterInstitute for Juvenile Research at the University of Illinois at Chicago, IL.
George M AndersonChild Study Center, Yale University, New Haven, CT.
Suma JacobUniversity of Minnesota, Minneapolis.
Matthew W MosconiKansas Center for Autism Research and Training, Overland Park. He is also with the Clinical Child Psychology Program and Schiefelbusch Institute for Life Span Studies at the University of Kansas, Lawrence.
John A SweeneyUniversity of Cincinnati, Ohio.
J Blake TurnerColumbia University Medical Center, New York, NY, and the New York State Psychiatric Institute, New York, NY.
James S SutcliffeVanderbilt University Medical Center, Nashville, TN.
Edwin H CookInstitute for Juvenile Research at the University of Illinois at Chicago, IL.
Jeremy Veenstra-VanderWeeleNew York State Psychiatric Institute, New York, NY, and the Center for Autism and the Developing Brain, New York-Presbyterian Hospital, White Plains, NY. They are also with the Sackler Institute for Developmental Psychobiology; Columbia University Medical Center, New York, NY. Electronic address: jeremy.veenstra@nyspi.columbia.edu.
University of Illinois Chicago · USCenter for Autism and Related Disorders · USColumbia University Irving Medical Center · USNew York Hospital Queens · USNewYork–Presbyterian Hospital · USNew York State Psychiatric InstituteUniversity of Cincinnati · USUniversity of Minnesota System · USVanderbilt University Medical Center · USYale University · US

Funding

VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
Translational Research Training in Child PsychiatryT32MH016434 · NIMH · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Cristiane S. Duarte, Kate Dimond Fitzgerald · 1985 to 2026
$10.9M
TRANS STUDIES OF COGNITIVE,AFFECTIVE/NEUROCHEMICAL PROCESSES UNDERLYING INSISTENCP50HD055751 · NICHD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI COOK, EDWIN H · 2007 to 2011
$9.5M
Neurobiological Signatures of Social Dysfunction and Repetitive BehaviorR01MH094604 · NIMH · VANDERBILT UNIVERSITY · PI VEENSTRA-VANDERWEELE, JEREMY · 2011 to 2015
$2.0M
NCRR NIH HHS UL1 RR024975NICHD NIH HHS P50 HD055751NIMH NIH HHS R01 MH094604NIMH NIH HHS T32 MH016434
6 · The paper itself

Abstract

objectiveThe serotonin (5-hydroxytryptamine [HT]) system has long been implicated in autism spectrum disorder (ASD). Whole-blood 5-HT level (WB5-HT) is a stable, heritable biomarker that is elevated in more than 25% of children with ASD. Recent findings indicate that the maternal 5-HT system may influence embryonic neurodevelopment, but maternal WB5-HT has not been examined in relation to ASD phenotypes.

methodWB5-HT levels were obtained from 181 individuals (3-27 years of age) diagnosed with ASD, 99 of their fathers, and 119 of their mothers. Standardized assessments were used to evaluate cognitive, behavioral, and language phenotypes.

resultsExploratory regression analyses found relationships between maternal WB5-HT and nonverbal IQ (NVIQ), Autism Diagnostic Interview-Revised (ADI-R) Nonverbal Communication Algorithm scores, and overall adaptive function on the Vineland Adaptive Behavior Scales-II. Latent class analysis identified a three-class structure in the assessment data, describing children with low, intermediate, and high severity across measures of behavior, cognition, and adaptive function. Mean maternal WB5-HT differed across classes, with the lowest maternal WB5-HT levels seen in the highest-severity group (Welch F

conclusionMaternal WB5-HT is associated with neurodevelopmental outcomes in offspring with ASD. Prospective, longitudinal studies will be needed to better understand the relationship between the function of the maternal serotonin system during pregnancy and brain development. Further studies in animal models may be able to reveal the mechanisms underlying these findings.

Indexed as

AdultAutism Spectrum DisorderBiomarkersChildCognitionFathersFemaleHumansMaleMothersNeuropsychological TestsProspective StudiesSerotoninBiomarkersSerotonin5-HTautism spectrum disorderhyperserotonemiamaternalserotonin

Identifiers

PMID30392628
PMCPMC6531860
OpenAlexW2893918249

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.